Two of the earliest closed-loop systems – those developed by Kadish and Shichiri – utilized a dual-hormone approach with a combination of insulin to counter hyperglycemia and glucagon to counter hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.